Mikhina Z P, Motorina L I, Glekov I V
Vopr Onkol. 1985;31(10):61-70.
The report presents the results of cranial irradiation of 44 small cell lung cancer patients with clinically-identified intracranial metastases and 40 patients for metastatic spread prevention. Whole brain irradiation was carried out with single doses of 2-4 Gy (total dose--30-40 Gy) in both groups 5 times weekly. Patients irradiated for metastasis prevention revealed a 3.3-fold decrease in intracranial metastasis frequency and a good post-treatment tolerance. In the other group, radiation failed to reach tumor lesions in 20%; treatment produced a poor effect in 30%. There was a correlation between survival time, initial expansion of process and tumor response to primary treatment. No relationship was observed between survival time and procedure and duration of cranial irradiation. Prophylactic irradiation may be beneficial in responders to therapy. However, randomized research into the effectiveness of preventive irradiation and possible radiation injury to cranial and brain tissues is required, particularly, in patients responding to primary treatment by complete regression of localized tumor.
该报告展示了对44例临床确诊有颅内转移的小细胞肺癌患者以及40例用于预防转移扩散的患者进行头颅照射的结果。两组均每周5次进行全脑照射,单次剂量为2 - 4 Gy(总剂量为30 - 40 Gy)。接受预防转移照射的患者颅内转移频率降低了3.3倍,且治疗后耐受性良好。在另一组中,20%的患者放疗未能到达肿瘤病灶;30%的患者治疗效果不佳。生存时间、疾病初始扩展情况与肿瘤对初始治疗的反应之间存在相关性。未观察到生存时间与放疗程序及疗程之间的关系。预防性放疗可能对治疗有反应的患者有益。然而,需要对预防性放疗的有效性以及对颅脑组织可能造成的放射性损伤进行随机研究,特别是对于局部肿瘤完全消退从而对初始治疗有反应的患者。